How to Help Your Patients Find Vuity in Stock: A Provider's Guide

You prescribe Vuity with confidence. But too often, the prescription never gets filled. The patient calls back: 'My pharmacy doesn't have it.' 'They said it will take a week.' 'It costs too much.' For a cash-pay drug with no insurance backstop and inconsistent pharmacy stocking, access barriers are significant — and they translate directly into unrealized outcomes for your patients.

This guide is designed for ophthalmologists, optometrists, and their clinical staff. It covers practical, actionable strategies to close the gap between writing a Vuity prescription and having your patient successfully using it.

Why the Fill Rate Problem Matters

Studies consistently show that prescription abandonment rates for specialty drugs are significantly higher than for generic medications. For a drug like Vuity — which has no insurance coverage, a cash price of $87-$162 per bottle, and inconsistent pharmacy stocking — the barriers are compounded. A patient who leaves your office with a prescription but never fills it is a lost therapeutic opportunity. It also creates noise in your practice: callbacks, rx transfers, and unnecessary follow-up calls.

Strategy 1: Identify 2-3 Local Pharmacies That Reliably Stock Vuity

The single most effective thing your office can do is identify which local pharmacies reliably stock Vuity and pilocarpine 1.25% generic. Call 5-8 pharmacies in your area once, compile the results, and give patients a handout with these specific pharmacy names and phone numbers. Update the list quarterly. This turns a recurring patient problem into a one-time office project.

Strategy 2: Write for Generic Pilocarpine 1.25% to Increase Flexibility

A generic pilocarpine 1.25% ophthalmic solution launched commercially in August 2025. Writing the prescription as 'pilocarpine hydrochloride 1.25% ophthalmic solution' or 'Vuity, substitution permitted' allows pharmacies to fill with whichever version they have available. This simple practice change can dramatically improve fill rates without compromising clinical outcomes.

Strategy 3: Counsel on Savings Options at the Point of Prescribing

Cost is a significant abandonment driver for Vuity. Without insurance coverage, the retail price is $87-$162 for a 30-day supply. Preemptively addressing this at the prescribing visit reduces sticker shock at the pharmacy. Key savings tools to mention:

My VUITY Points (MVP) Loyalty Program: Allergan's patient loyalty program for eligible US patients (not available to government insurance enrollees including Medicare/Medicaid).

GoodRx: Can reduce the pilocarpine 1.25% cost to approximately $24-27 at participating pharmacies.

FSA/HSA eligibility: Vuity is a prescription medication, making it eligible for FSA and HSA reimbursement.

Strategy 4: Consider In-Office Dispensing

Many ophthalmology and optometry practices stock ophthalmic medications for dispensing at the point of care. For a cash-pay medication like Vuity, in-office dispensing eliminates the pharmacy access barrier entirely. Patients leave with medication in hand, improving first-fill adherence. If you're not currently doing in-office dispensing, this is worth discussing with your practice administrator.

Strategy 5: Provide a Sample First

Allergan sales representatives can provide sample vials of Vuity. A trial approach — using a sample in office and checking vision 30-60 minutes post-instillation — helps identify responders before they commit to a cash-pay prescription. Non-responders are identified early, saving them money and frustration. Responders have a much stronger motivation to navigate any pharmacy barriers.

Strategy 6: Direct Patients to medfinder

medfinder is a pharmacy location service that calls pharmacies on the patient's behalf to find which ones have a specific medication in stock. For Vuity — a drug with patchy pharmacy availability — this is particularly useful. Direct patients to medfinder.com/providers to help them find pharmacies near them with Vuity in stock, without placing the call burden on your staff.

Strategy 7: Have a Backup Prescription Ready

For patients who are strong Vuity candidates but face consistent access issues, consider having a backup prescription for Qlosi (pilocarpine 0.4%) or Vizz (aceclidine 1.44%). Both are FDA-approved, clinically validated alternatives. Having the conversation at the prescribing visit — 'If you can't find Vuity, here is an alternative I'm comfortable with' — empowers the patient and reduces follow-up friction.

Staff Training: Who Should Know What

Your front desk and clinical staff are often the first point of contact when a patient calls about a fill issue. Train them to:

Know the list of local pharmacies that stock Vuity

Know that the generic pilocarpine 1.25% is an equivalent alternative

Know the GoodRx and MVP savings program options to share with patients

Know when to escalate to the prescriber (repeated failures, clinical side effects, need to switch medications)

The Provider's Role in Patient Adherence

The gap between prescription and fill is a systems problem, not just a patient problem. As the prescriber, proactively addressing cost and access at the point of care is one of the most impactful things you can do to improve outcomes. For more clinical background, see our article Vuity Availability: What Providers and Prescribers Need to Know in 2026.